WMSA
Weiss Multi-Strategy Advisers’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,480
| Closed | -$1.51M | – | 282 |
|
|
2023
Q4 | $1.51M | Buy |
+11,480
| New | +$1.51M | 0.04% | 357 |
|
|
2022
Q3 | – | Sell |
-27,070
| Closed | -$2.64M | – | 693 |
|
|
2022
Q2 | $2.64M | Buy |
27,070
+7,070
| +35% | +$689K | 0.08% | 332 |
|
|
2022
Q1 | $1.88M | Sell |
20,000
-14,105
| -41% | -$1.32M | 0.04% | 401 |
|
|
2021
Q4 | $2.91M | Buy |
34,105
+1,161
| +4% | +$98.9K | 0.07% | 317 |
|
|
2021
Q3 | $3.16M | Buy |
32,944
+720
| +2% | +$69.1K | 0.07% | 329 |
|
|
2021
Q2 | $3.14M | Buy |
32,224
+1,152
| +4% | +$112K | 0.07% | 327 |
|
|
2021
Q1 | $3.02M | Sell |
31,072
-4,159
| -12% | -$404K | 0.07% | 335 |
|
|
2020
Q4 | $3.38M | Sell |
35,231
-5,028
| -12% | -$482K | 0.07% | 307 |
|
|
2020
Q3 | $3.87M | Sell |
40,259
-2,241
| -5% | -$215K | 0.1% | 260 |
|
|
2020
Q2 | $5.19M | Sell |
42,500
-8,379
| -16% | -$1.02M | 0.15% | 198 |
|
|
2020
Q1 | $4.4M | Sell |
50,879
-2,121
| -4% | -$184K | 0.17% | 169 |
|
|
2019
Q4 | $5.7M | Buy |
53,000
+3,000
| +6% | +$322K | 0.09% | 229 |
|
|
2019
Q3 | $4.51M | Sell |
50,000
-15,000
| -23% | -$1.35M | 0.09% | 188 |
|
|
2019
Q2 | $5.49M | Hold |
65,000
| – | – | 0.15% | 120 |
|
|
2019
Q1 | $5.73M | Sell |
65,000
-1,000
| -2% | -$88.1K | 0.14% | 142 |
|
|
2018
Q4 | $4.71M | Sell |
66,000
-19,000
| -22% | -$1.36M | 0.2% | 112 |
|
|
2018
Q3 | $10.5M | Sell |
85,000
-2,319
| -3% | -$285K | 0.28% | 71 |
|
|
2018
Q2 | $8.58M | Buy |
87,319
+12,319
| +16% | +$1.21M | 0.21% | 112 |
|
|
2018
Q1 | $6.22M | Buy |
75,000
+33,000
| +79% | +$2.74M | 0.2% | 107 |
|
|
2017
Q4 | $3.26M | Buy |
42,000
+7,000
| +20% | +$543K | 0.08% | 193 |
|
|
2017
Q3 | $2.15M | Buy |
35,000
+4,000
| +13% | +$245K | 0.08% | 244 |
|
|
2017
Q2 | $1.43M | Sell |
31,000
-1,500
| -5% | -$69K | 0.06% | 275 |
|
|
2017
Q1 | $1.41M | Sell |
32,500
-3,500
| -10% | -$152K | 0.06% | 282 |
|
|
2016
Q4 | $1.39M | Buy |
36,000
+5,000
| +16% | +$193K | 0.07% | 218 |
|
|
2016
Q3 | $1.57M | Sell |
31,000
-347
| -1% | -$17.6K | 0.1% | 195 |
|
|
2016
Q2 | $1.43M | Buy |
31,347
+347
| +1% | +$15.8K | 0.11% | 196 |
|
|
2016
Q1 | $1.23M | Buy |
31,000
+14,000
| +82% | +$554K | 0.05% | 277 |
|
|
2015
Q4 | $962K | Hold |
17,000
| – | – | 0.07% | 210 |
|
|
2015
Q3 | $676K | Buy |
17,000
+1,500
| +10% | +$59.6K | 0.03% | 250 |
|
|
2015
Q2 | $740K | Buy |
15,500
+6,000
| +63% | +$286K | 0.03% | 300 |
|
|
2015
Q1 | $377K | Sell |
9,500
-500
| -5% | -$19.8K | 0.02% | 349 |
|
|
2014
Q4 | $223K | Sell |
10,000
-10,000
| -50% | -$223K | 0.01% | 333 |
|
|
2014
Q3 | $313K | Hold |
20,000
| – | – | 0.01% | 406 |
|
|
2014
Q2 | $297K | Buy |
+20,000
| New | +$297K | 0.01% | 576 |
|
|
2014
Q1 | – | Sell |
-18,750
| Closed | -$175K | – | 996 |
|
|
2013
Q4 | $175K | Buy |
+18,750
| New | +$175K | ﹤0.01% | 856 |
|
|
2013
Q3 | – | Sell |
-150,000
| Closed | -$2.01M | – | 891 |
|
|
2013
Q2 | $2.01M | Buy |
+150,000
| New | +$2.01M | 0.06% | 297 |
|